de Mello RA - Search Results

1

Insight into p95HER2 in breast cancer: molecular mechanisms and targeted therapies.

de Mello RA, de Vasconcelos A, Ribeiro RA, Pousa I, Afonso N, Pereira D, Rodrigues H. de Mello RA, et al. Among authors: de vasconcelos a. Recent Pat DNA Gene Seq. 2012 Apr;6(1):56-63. doi: 10.2174/187221512799303109. Recent Pat DNA Gene Seq. 2012. PMID: 22239685 Review.

2

Nivolumab for advanced squamous cell lung cancer: what are the next steps?

de Mello RA, Pousa I, Pereira D. de Mello RA, et al. Lancet Oncol. 2015 Mar;16(3):234-5. doi: 10.1016/S1470-2045(15)70074-4. Epub 2015 Feb 20. Lancet Oncol. 2015. PMID: 25704436 No abstract available.

3

Immunotherapy for lung cancer: for whom the bell tolls?

Madureira P, de Mello RA, de Vasconcelos A, Zhang Y. Madureira P, et al. Among authors: de mello ra, de vasconcelos a. Tumour Biol. 2015 Mar;36(3):1411-22. doi: 10.1007/s13277-015-3285-6. Epub 2015 Mar 4. Tumour Biol. 2015. PMID: 25736929 Review.

4

Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies.

Luis M, Tavares A, Carvalho LS, Lara-Santos L, Araújo A, de Mello RA. Luis M, et al. Among authors: de mello ra. World J Gastroenterol. 2013 Oct 14;19(38):6383-97. doi: 10.3748/wjg.v19.i38.6383. World J Gastroenterol. 2013. PMID: 24151357 Free PMC article. Review.

5

Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies.

de Mello RA, Costa BM, Reis RM, Hespanhol V. de Mello RA, et al. Recent Pat Anticancer Drug Discov. 2012 Jan;7(1):118-31. doi: 10.2174/157489212798357994. Recent Pat Anticancer Drug Discov. 2012. PMID: 21854359 Free article. Review.

6

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies.

Monteiro Ide P, Madureira P, de Vasconscelos A, Pozza DH, de Mello RA. Monteiro Ide P, et al. Among authors: de mello ra, de vasconscelos a. Pharmacogenomics. 2015;16(3):257-71. doi: 10.2217/pgs.14.133. Pharmacogenomics. 2015. PMID: 25712189 Review.

7

HER2 therapies and gastric cancer: a step forward.

de Mello RA, Marques AM, Araújo A. de Mello RA, et al. World J Gastroenterol. 2013 Oct 7;19(37):6165-9. doi: 10.3748/wjg.v19.i37.6165. World J Gastroenterol. 2013. PMID: 24115812 Free PMC article. Review.

8

Immunotherapy and lung cancer: current developments and novel targeted therapies.

Domingues D, Turner A, Silva MD, Marques DS, Mellidez JC, Wannesson L, Mountzios G, de Mello RA. Domingues D, et al. Among authors: de mello ra. Immunotherapy. 2014;6(11):1221-35. doi: 10.2217/imt.14.82. Immunotherapy. 2014. PMID: 25496336 Review.

9

Epidermal growth factor receptor and metastatic colorectal cancer: insights into target therapies.

de Mello RA, Marques AM, Araújo A. de Mello RA, et al. World J Gastroenterol. 2013 Oct 14;19(38):6315-8. doi: 10.3748/wjg.v19.i38.6315. World J Gastroenterol. 2013. PMID: 24151349 Free PMC article. Review.

10

Challenges in Lung Cancer Approaches: from the Clinical Issues to the Novel Therapies.

Coelho SP, Capelas ML, Alves SM, Sá L, de Mello RA. Coelho SP, et al. Among authors: de mello ra. Recent Adv DNA Gene Seq. 2015;9(1):45-50. doi: 10.2174/2352092210666151214110725. Recent Adv DNA Gene Seq. 2015. PMID: 26655954 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters